Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Ultra Nasdaq Biotechnology 2X ETF (BIB)

Ultra Nasdaq Biotechnology 2X ETF (BIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family ProShares
  • Assets Under Management 85,215,000
  • Shares Outstanding, K 1,380
  • 60-Month Beta 1.63
  • Price/Earnings ttm 0.00
  • Annual Dividend & Yield 0.50 (0.80%)
  • Most Recent Dividend 0.153 on 09/25/24
  • Management Fee 0.95%
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 37.90% ( +1.45%)
  • Historical Volatility 31.42%
  • IV Percentile 68%
  • IV Rank 53.05%
  • IV High 59.01% on 08/05/24
  • IV Low 14.05% on 05/24/24
  • Put/Call Vol Ratio 5.60
  • Today's Volume 33
  • Volume Avg (30-Day) 10
  • Put/Call OI Ratio 0.91
  • Today's Open Interest 383
  • Open Int (30-Day) 368

Price Performance

See More
Period Period Low Period High Performance
1-Month
60.16 +0.75%
on 10/31/24
68.00 -10.87%
on 11/11/24
-3.30 (-5.16%)
since 10/14/24
3-Month
60.16 +0.75%
on 10/31/24
69.17 -12.38%
on 09/19/24
-1.73 (-2.78%)
since 08/14/24
52-Week
42.42 +42.88%
on 11/16/23
69.56 -12.87%
on 07/26/24
+16.99 (+38.95%)
since 11/14/23

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Sell with a Average short term outlook on maintaining the current direction.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Fund Summary

The ProShares Ultra Nasdaq Biotechnology seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the NASDAQ Biotechnology Index.

See More

Top 10 Holdings

Name % Holdings
Ultra Nasdaq Biotechnology 2X ETF 0.00%
NASDAQ Bio Index SWAP BNP Paribas 0.00%
NASDAQ Biotechnology Index SWAP Bank of America NA 0.00%
NASDAQ Biotechnology Index SWAP UBS AG 0.00%
NASDAQ Biotechnology Index SWAP Goldman Sachs International 0.00%
NASDAQ Biotechnology Index SWAP Societe Generale 0.00%
NASDAQ Biotechnology Index SWAP Citibank NA 0.00%
NASDAQ Biotechnology Index SWAP Morgan Stanley & Co. International PLC 0.00%
TREASURY BILL 0.00%
Gilead Sciences Inc 0.00%

See More

Key Turning Points

3rd Resistance Point 65.59
2nd Resistance Point 64.82
1st Resistance Point 63.28
Last Price 60.00
1st Support Level 60.97
2nd Support Level 60.20
3rd Support Level 58.66

See More

52-Week High 69.56
Last Price 60.00
Fibonacci 61.8% 59.19
Fibonacci 50% 55.99
Fibonacci 38.2% 52.79
52-Week Low 42.42

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar